Category Archives: cancer drugs

The ‘cancer drugs scandal’: decision-making and the need to involve patients at every level

When will there be the level of user involvement in healthcare necessary to ensure patients get the information they need to make the decisions they want? ‘Nothing about us without us’: patients need the opportunity to be included in multidisciplinary … Continue reading

Posted in Campaigns, cancer, cancer drugs, citizen safety, clinical trials, Compassion in healthcare, diagnoses, dignity in dying, dying, healthcare modernisation, information, informed consent, medicine's flaws, multidisciplinary team meetings (MTDs), openness, Over-medicalisation, overdiagnosis, overtreatment, palliative care, patient safety, patient/doctor communication, patient/public involvement, personal autonomy, Public safety, rarer and uncommon cancers, speaking out | Tagged , , , , , | Leave a comment

The evolving cancer drugs fund

‘The evolution of the cancer drug appraisal process: hosted by BMJ, this promotional campaign article by Roche includes ‘How will it work?’, ‘Implications for breast cancer’, and ‘consequences for HER2+ breast cancer – coming soon’. ‘…A new model was introduced … Continue reading

Posted in Breast Cancer, Campaigns, cancer drugs, healthcare modernisation, patient safety | Tagged , , | Leave a comment

Major cuts to Cancer Drugs Fund List.

National Cancer Drugs Fund List is cut back: Last Friday, NHS England announced a series of cuts to the National CDF list. This is what Andrew Wilson, CEO, The Rarer Cancers Foundation reports: “We have taken a robust line in … Continue reading

Posted in Campaigns, cancer drugs, citizen safety, Compassion in healthcare, dying | Tagged , , , , | Leave a comment